BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30621563)

  • 1. GPCR Allosteric Modulators: Mechanistic Advantages and Therapeutic Applications.
    Wold EA; Zhou J
    Curr Top Med Chem; 2018; 18(23):2002-2006. PubMed ID: 30621563
    [No Abstract]   [Full Text] [Related]  

  • 2. Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.
    Leach K; Sexton PM; Christopoulos A
    Trends Pharmacol Sci; 2007 Aug; 28(8):382-9. PubMed ID: 17629965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S; Zhang J
    J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric properties of G protein-coupled receptor oligomers.
    Springael JY; Urizar E; Costagliola S; Vassart G; Parmentier M
    Pharmacol Ther; 2007 Sep; 115(3):410-8. PubMed ID: 17655934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthosteric- and allosteric-induced ligand-directed trafficking at GPCRs.
    Digby GJ; Conn PJ; Lindsley CW
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):587-94. PubMed ID: 20812150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pharmacological effect of allosteric regulation at GPCR heterodimer].
    Zhang N; Chen J; Gong L; Liu LL; Bai B
    Sheng Li Ke Xue Jin Zhan; 2013 Apr; 44(2):93-8. PubMed ID: 23847918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulators of G-protein-coupled receptors.
    May LT; Christopoulos A
    Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In search of negative allosteric modulators of biological targets.
    Groebe DR
    Drug Discov Today; 2009 Jan; 14(1-2):41-9. PubMed ID: 18973826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allosteric modulator of GPCRs and new drug targets].
    Wei RS; He SP
    Sheng Li Ke Xue Jin Zhan; 2012 Dec; 43(6):459-62. PubMed ID: 23520767
    [No Abstract]   [Full Text] [Related]  

  • 10. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
    Janero DR; Thakur GA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric Modulators of the Class A G Protein Coupled Receptors.
    Tschammer N
    Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating structural and mutagenesis data to elucidate GPCR ligand binding.
    Munk C; Harpsøe K; Hauser AS; Isberg V; Gloriam DE
    Curr Opin Pharmacol; 2016 Oct; 30():51-58. PubMed ID: 27475047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
    Bartuzi D; Kaczor AA; Matosiuk D
    Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric communication pipelines in G-protein-coupled receptors.
    Vaidehi N; Bhattacharya S
    Curr Opin Pharmacol; 2016 Oct; 30():76-83. PubMed ID: 27497048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
    Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
    Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for allosteric sites on receptors.
    Wenthur CJ; Gentry PR; Mathews TP; Lindsley CW
    Annu Rev Pharmacol Toxicol; 2014; 54():165-84. PubMed ID: 24111540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders.
    Gregory KJ; Noetzel MJ; Niswender CM
    Prog Mol Biol Transl Sci; 2013; 115():61-121. PubMed ID: 23415092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for positive allosteric modulators of biological targets.
    Groebe DR
    Drug Discov Today; 2006 Jul; 11(13-14):632-9. PubMed ID: 16793532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding time for allosteric interactions.
    Wainer IW
    Nat Biotechnol; 2004 Nov; 22(11):1376-7. PubMed ID: 15529160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.